US nurses charmed by NMT's (New Medical Technology's) retraction technology:
This article was originally published in Clinica
The US charitable care provider, the Visiting Nurses Association of America (VNAA), has entered a purchase agreement with the UK's New Medical Technology Group (Livingstone, Scotland) for the supply of its safety needle syringe incorporating automatic needle retraction technology. VNAA director Jean Ellis said the Boston, Massachusetts-based association sees provision of the safety syringes as helping to reduce needlestick incidents and as providing cost-effective care. Every year, some 600,000 needlestick incidents occur in the US alone.
You may also be interested in...
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.